CIM Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $255K | Sell |
|
|||||
|
2025
Q2 | $569K | Buy |
|
|||||
|
2025
Q1 | $292K | Hold |
|
|||||
|
2024
Q4 | $328K | Buy |
|
|||||
|
2024
Q3 | $483K | Sell |
|
|||||
|
2024
Q2 | $492K | Sell |
|
|||||
|
2024
Q1 | $453K | Hold |
|
|||||
|
2023
Q4 | $414K | Sell |
|
|||||
|
2023
Q3 | $552K | Sell |
|
|||||
|
2023
Q2 | $490K | Buy |
|
|||||
|
2023
Q1 | $559K | Buy |
|
|||||
|
2022
Q4 | $410K | Sell |
|
|||||
|
2022
Q3 | $398K | Buy |
|
|||||
|
2022
Q2 | $327K | Sell |
|
|||||
|
2022
Q1 | $389K | Sell |
|
|||||
|
2021
Q4 | $671K | Sell |
|
|||||
|
2021
Q3 | $654K | Sell |
|
|||||
|
2021
Q2 | $607K | Sell |
|
|||||
|
2021
Q1 | $523K | Sell |
|
|||||
|
2020
Q4 | $553K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $374K | Hold |
|
|||||
|
2019
Q3 | $276K | Sell |
|
|||||
|
2019
Q2 | $345K | Buy |
|
|||||
|
2019
Q1 | $435K | Hold |
|
|||||
|
2018
Q4 | $396K | Sell |
|
|||||
|
2018
Q3 | $446K | Hold |
|
|||||
|
2018
Q2 | $381K | Sell |
|
|||||
|
2018
Q1 | $391K | Sell |
|
|||||
|
2017
Q4 | $437K | Sell |
|
|||||
|
2017
Q3 | $528K | Sell |
|
|||||
|
2017
Q2 | $613K | Sell |
|
|||||
|
2017
Q1 | $978K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $874K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.25M | Sell |
|
|||||
|
2014
Q1 | $1.36M | Sell |
|
|||||
|
2013
Q4 | $1.28M | Buy |
|
|||||
|
2013
Q3 | $1.35M | Buy |
|